Pliant Therapeutics Inc (NASDAQ: PLRX) is -76.69% lower on its value in year-to-date trading and has touched a low of $7.18 and a high of $18.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PLRX stock was last observed hovering at around $7.79 in the last trading session, with the day’s loss setting it -4.72%.
Currently trading at $3.07, the stock is -71.37% and -75.50% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 19.98 million and changing -60.59% at the moment leaves the stock -75.86% off its SMA200. PLRX registered -80.78% loss for a year compared to 6-month gain of -74.96%. The firm has a 50-day simple moving average (SMA 50) of $12.7384 and a 200-day simple moving average (SMA200) of $12.7672.
The stock witnessed a -75.65% loss in the last 1 month and extending the period to 3 months gives it a -80.45%, and is -72.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.62% over the week and 9.92% over the month.
Pliant Therapeutics Inc (PLRX) has around 158 employees, a market worth around $186.82M and $0.00M in sales. Distance from 52-week low is -57.24% and -82.94% from its 52-week high. The company has generated returns on investments over the last 12 months (-49.71%).
The EPS is expected to shrink by -32.10% this year, but quarterly earnings will post -100.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Pliant Therapeutics Inc (PLRX) Top Institutional Holders
238.0 institutions hold shares in Pliant Therapeutics Inc (PLRX), with institutional investors hold 115.76% of the company’s shares. The shares outstanding are 60.85M, and float is at 53.50M with Short Float at 14.09%. Institutions hold 111.95% of the Float.
The top institutional shareholder in the company is DEEP TRACK CAPITAL, LP with over 5.97 million shares valued at $64.2 million. The investor’s holdings represent 9.9238% of the PLRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 4.97 million shares valued at $53.45 million to account for 8.2612 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 4.6 million shares representing 7.6475% and valued at over $49.48 million, while FMR LLC holds 6.5 of the shares totaling 3.91 million with a market value of $42.05 million.
Pliant Therapeutics Inc (PLRX) Insider Activity
The most recent transaction is an insider sale by Coulie Bernard, the company’s President and CEO. SEC filings show that Coulie Bernard sold 52,419 shares of the company’s common stock on Jan 17 ’25 at a price of $11.20 per share for a total of $0.59 million. Following the sale, the insider now owns 0.43 million shares.
Pliant Therapeutics Inc disclosed in a document filed with the SEC on Jan 17 ’25 that Cummings Keith Lamont (Chief Financial Officer) sold a total of 20,148 shares of the company’s common stock. The trade occurred on Jan 17 ’25 and was made at $11.20 per share for $0.23 million. Following the transaction, the insider now directly holds 0.26 million shares of the PLRX stock.
Still, SEC filings show that on Jan 17 ’25, Hull Hans (Chief Business Officer) disposed off 15,936 shares at an average price of $11.20 for $0.18 million. The insider now directly holds 211,558 shares of Pliant Therapeutics Inc (PLRX).
